上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1198Please respect copyright.PENANAc5EUMilQVr
1198Please respect copyright.PENANAOR1RSytjxm
上集:https://www.penana.com/article/4711251198Please respect copyright.PENANAKnptcBUBJd
1198Please respect copyright.PENANAFIjH0EWFfS
1198Please respect copyright.PENANApWtxqK6yF4
1198Please respect copyright.PENANAP5VcN9aONR
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1198Please respect copyright.PENANAXRM4Dhfxpj
1198Please respect copyright.PENANAt6X7TpARZu
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1198Please respect copyright.PENANAwM8bFOrrrX
1198Please respect copyright.PENANAYwolekZdlI
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1198Please respect copyright.PENANAyj7J9J92yq
1198Please respect copyright.PENANAtv0Y9cH27w
1198Please respect copyright.PENANA2EfOfxGpz7
1198Please respect copyright.PENANAOwNu19wWOv
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1198Please respect copyright.PENANAtRB756o7sh
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1198Please respect copyright.PENANAkhomgecAb1
1198Please respect copyright.PENANAjP6JpcDcko
忘記甚麼是Neoantigen的話,可重溫上一集。1198Please respect copyright.PENANAVBrlmVNVYu
1198Please respect copyright.PENANAlp7OmSW3dd
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1198Please respect copyright.PENANAARqJM1Hjns
1198Please respect copyright.PENANAmpyTStF6uf
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1198Please respect copyright.PENANAdVYyJ5C0uJ
1198Please respect copyright.PENANA6063a0Von3
1198Please respect copyright.PENANA5dN3GLMlaJ
1198Please respect copyright.PENANAzTz4a7FmzB
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1198Please respect copyright.PENANAO7Y3TP8ljx
1198Please respect copyright.PENANANnFedezCUM
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1198Please respect copyright.PENANATLC3FhyGDm
1198Please respect copyright.PENANASe9xSAfq5W
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1198Please respect copyright.PENANAH2qNImiwiA
1198Please respect copyright.PENANAdYuWIDkA30
1198Please respect copyright.PENANA8xSZzwPdOZ
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1198Please respect copyright.PENANAd8LCqBmEaS
1198Please respect copyright.PENANAQYJjQEHscl
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1198Please respect copyright.PENANA6B0jLTtgQb
1198Please respect copyright.PENANARKA2kYUJEd
1198Please respect copyright.PENANAS11pGMBMSh
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1198Please respect copyright.PENANAvxre4JxRuy
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1198Please respect copyright.PENANAWLonv6xhyO
1198Please respect copyright.PENANAbaFmvzV3t5
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1198Please respect copyright.PENANA0zJ0Ze0OUh
1198Please respect copyright.PENANA4DtIWkDLZo
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1198Please respect copyright.PENANAbo1mwxP9OM
1198Please respect copyright.PENANAcFlKkmHuYJ
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1198Please respect copyright.PENANARXX7LnmTNq
1198Please respect copyright.PENANAHUJBZq4gfg
1198Please respect copyright.PENANA2AaI1BNIbB
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1198Please respect copyright.PENANADXvZW2g4hU
1198Please respect copyright.PENANACxfNhW1vNY
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1198Please respect copyright.PENANA4SuLunfBcn
1198Please respect copyright.PENANAd4PGEuukzl
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1198Please respect copyright.PENANAfwGfIGqug5
1198Please respect copyright.PENANAdOyRZDAdvS
Link:1198Please respect copyright.PENANAv3dZlq8SPR
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1198Please respect copyright.PENANAF4B9ZTCWGK
1198Please respect copyright.PENANAgSimKHDMwc
1198Please respect copyright.PENANAsjOl7wiWIz
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1198Please respect copyright.PENANAP9iEKY2ATU